ACURATE neo2™ and ACURATE Prime™
Aortic Valve System
ACURATE neo2™ and ACURATE Prime™ aortic valve systems.
Boston Scientific has discontinued worldwide sales of the ACURATE neo2™ and ACURATE Prime™ Aortic Valve Systems.
Patients who have been treated with an ACURATE neo2 or ACURATE Prime valve should continue to follow standard of care, and any additional patient management should be at the discretion of their physician on an individualized basis.
While data continue to support the performance of the ACURATE valve system when the product’s optimized instructions for use are followed, this decision was made due to the increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions.
For Patients
If you are a patient with an ACURATE valve and have specific questions about your clinical care, please discuss with your doctor.
For HCPs
For HCPs that would like more information, please contact your Boston Scientific sales representative.